This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dapagliflozin Preserves Vascular Endothelial Function and Improves Glycemic Control in High CV Risk Patients with Type 2 Diabetes Mellitus: Edified Study. (15th December 2018)
Record Type:
Journal Article
Title:
Dapagliflozin Preserves Vascular Endothelial Function and Improves Glycemic Control in High CV Risk Patients with Type 2 Diabetes Mellitus: Edified Study. (15th December 2018)
Main Title:
Dapagliflozin Preserves Vascular Endothelial Function and Improves Glycemic Control in High CV Risk Patients with Type 2 Diabetes Mellitus: Edified Study